Nicola Currey - Concepedia

Author

Nicola Currey

Garvan Institute of Medical Research

Also Known As

N Currey, N. Currey, Nicola Currey

Publications

615

Citations

H-Index

Concepts

All Affiliations

Garvan Institute of Medical Research St Vincent's Clinic UNSW Sydney Western Sydney University The University of Sydney

About

Nicola Currey is an author at Garvan Institute of Medical Research specializing in medicine, cell signaling, and cancer cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	86
2	Cell Biology	3	3	86
3	Cancer Cell Biology	3	3	86
4	Natural Sciences	1	1	30
5	Molecular Biology	1	1	30

Nicola Currey

Publications

597

Citations

H-Index

Page 1

	Year	Citations
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis Claire Vennin, Venessa Chin, Sean Warren, Science Translational Medicine	2017	262
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma T J Seng, Nicola Currey, Wendy A. Cooper, British Journal of Cancer	2008	100
<i>KRAS</i> mutations and <i>CDKN2A</i> promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer Maija R.J. Kohonen‐Corish, Jason Tseung, Charles Chan, International Journal of Cancer	2013	49
The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon Dessislava Mladenova, Joseph J. Daniel, Jane E. Dahlstrom, Gut	2010	33
MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm Laurent Pangon, Dessislava Mladenova, Lauren Watkins, International Journal of Cancer Sirt1 Inhibitor NicotinamideMolecular BiologyCancer BiologyTumor BiologyTranscriptional Regulation	2014	30
‘MCC’ protein interacts with E-cadherin and β-catenin strengthening cell–cell adhesion of HCT116 colon cancer cells Fahad Benthani, David Herrmann, Phuong Tran, Oncogene Tumor BiologySignaling PathwayMedicineCell AdhesionCancer Cell Biology	2017	30
Sulindac activates NF-κB signaling in colon cancer cells Dessislava Mladenova, Laurent Pangon, Nicola Currey, Cell Communication and Signaling	2013	27
JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer Laurent Pangon, Irvin Ng, Marc Giry-Laterrière, Oncogene Transcriptional RegulationSystems Biologyβ-Catenin Transcriptional ActivitySignaling PathwayCell Regulation	2015	26
HIF1α deficiency reduces colon inflammation in a mouse model of proximal colon cancer Dessislava Mladenova, Jane E. Dahlstrom, Phuong Tran, Disease Models & Mechanisms	2015	17
Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer Nicola Currey, Zeenat Jahan, C. Elizabeth Caldon, Cellular and Molecular Gastroenterology and Hepatology	2019	13

Page 1